March 30, 2011 -- FDA has announced that Meds IV of Birmingham, AL, has recalled some 26 IV bag products suspected to be the source of the bacteria related hospital deaths and sickness in 6 Alabama hospitals within the last days. The products are all IV bag solutions and range from nutrition to narcotics commonly administered in hospital and some out-patient settings.
FDA has issued the recall alert, which can be found at
March 30, 2011 -- The FDA is alerting the public that the new blood-thinner option, Pradaxa, will degrade and become less potent if taken out of its original packaging. Many senior citizens and people on multiple medications and vitamins use pill boxes to put 7 or 30 day supplies of medicine in one daily compartment. But if Pradaxa is removed from its bubble pack or from the pill bottle with a special drying component that also requires you put the lid back on tightly, then it becomes susceptible to moisture and may lose its potency as a blood thinner.
So, FDA says store Pradaxa in its original bottle or bubble pack until use and closely follow the instructions. Pradaxa has been touted as the new Coumadin (warfarin) with less complicated administration, side effects and contraindications.
Pradaxa is made by Boehringer Ingelheim and costs nearly $3.40 a pill. FDA wants the word out on the special handling requirements. More information can be found at www.fda.gov, or the manufacturer's website at pradaxa.com
March 29, 2011 -- FDA and Greenstone LLC announced the recall of the depression drug Citalopram and protatic drug Finasteride because there appears to have been labeling mixups between the two drugs by the third party manufacturer. Some of the bottles may contain the other drug. In addition to the obvious reasons not to take a wrong drug or abrupt stoping of a prescribed drug, Finasteride in particular should not be handled by pregnant women because it can cause birth defects. The recall includes Citalopram 10 mg tablets in 100-count bottles and Finasteride 5 mg tablets in 90-count bottles and both were distributed in the U.S.
For more information see the recall notice at
March 29, 2011 -- FDA and Candy Dynamics of Indianapolis, IN, have announced the recall of Short Circuits bubble gum sold throughout the U.S. and Canada in retail stores and through mail orders. The recall is due to elevated levels of lead. This could cause problems for anyone chewing the gum and, in particular, children and pregnant women. Anyone with gum labeled Short Circuits should contact Candy Dynamics for information on how to destroy the product at 317-228-5012.
In an oddly prophetic way, the product is officially identified as Toxic Waste Short Circuits Bubble Gum, 3.2 oz size, Lot #15070SC12. The Lot number is located on the left side of the bag. The bubble gum is manufactured in Pakistan.
For the recall notice use the link below.
Page 6 of 15
Sanford Law FirmPrincipal Office in Houston, Texas
Source Texas Lawyer newsfeed.
Top stories in Texas La, updated every hour.
Source law.com Supreme Court Monitor newsfeed.
Latest news from the Supreme Court Monitor.
Copyright 2014 Shelly A Sanford PLLC. All Rights Reserved.
Website by Media A-Team, Inc.